RSV season is approaching, are you ready to protect your youngest patients?
We’re excited to share an upcoming 45-minute educational webinar hosted by Sanofi, designed to support healthcare providers in implementing Beyfortus® (nirsevimab-alip) into their practices.
This session will cover:
- The serious risk RSV poses to infants, including those born before the RSV season.
- Robust data on Beyfortus®, the first long-acting monoclonal antibody for RSV prevention in infants.
- Practical guidance on implementing Beyfortus®, aligned with AAP, ACIP, and CDC recommendations.
Whether you’re already familiar with Beyfortus® or just beginning to explore RSV prevention strategies, this webinar offers valuable insights and actionable steps.
Choose your session
- August 13, 2025 at 12:00 PM EST – Register here
- August 13, 2025 at 3:00 PM EST – Register here
Don’t miss this opportunity to enhance your RSV prevention strategy and better protect the infants in your care.
Questions
If your practice has any questions or needs assistance with your RSV vaccine purchases, please contact us at cpp@nationwidechildren.org.